NEW YORK – Stratify Genomics said on Monday that it has partnered with PWNHealth to offer Stratify's prostate cancer genetic risk test directly to consumers with medical oversight.
Specifically, Stratify and PWNHealth will provide clinical oversight and patient support for Stratify's Prompt Personal Genetic Score (PGS) through the Stratify online portal.